Neuroinflammation has emerged as a shared molecular mechanism in epilepsy and cognitive impairment. offering new insights into the complex interplay between immune responses and brain function. Evidence reveals involvement of High mobility group box 1 (HMGB1) in blood-brain barrier disruption and correlations with epilepsy severity and drug resistance. While anti-inflammatory treatmen... https://www.bempresas.com/